Transcriptomics and the mechanisms of antidepressant efficacy

European Neuropsychopharmacology

Volumn 26, Issue 1, 2016, Pages 105-112

  Hodgson, Karen ^a   Tansey, Katherine E ^a   Powell, Timothy R ^a   Coppola, Giovanni ^b,c   Uher, Rudolf ^a,d   Zvezdana Dernovšek, Mojca ^e   Mors, Ole ^f,p   Hauser, Joanna ^g   Souery, Daniel ^h   Maier, Wolfgang ⁱ   Henigsberg, Neven ^j   Rietschel, Marcella ^k   Placentino, Anna ^l   Aitchison, Katherine J ^a,m   Craig, Ian W ^a   Farmer, Anne E ^a   Breen, Gerome ^a   McGuffin, Peter ^a   Dobson, Richard ^n,o  

^a MEDICAL RESEARCH COUNCIL   (United Kingdom)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d DALHOUSIE UNIVERSITY   (Canada)

^e University Psychiatric Clinic   (Slovenia)

^f AARHUS UNIVERSITY HOSPITAL   (Denmark)

^g POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^h UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

ⁱ UNIVERSITY OF BONN   (Germany)

^j UNIVERSITY OF ZAGREB   (Croatia)

^k CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

^l SPEDALI CIVILI   (Italy)

^m UNIVERSITY OF ALBERTA   (Canada)

ⁿ KING'S COLLEGE LONDON   (United Kingdom)

^o SOUTH LONDON AND MAUDSLEY NHS FOUNDATION TRUST   (United Kingdom)

^p H LUNDBECK A S   (Denmark)

more..

Author keywords

Antidepressants; Gene expression; Genetics; Major Depressive Disorder; Pharmacogenetics; Transcriptomics

Indexed keywords

ANTIDEPRESSANT AGENT; ESCITALOPRAM; NORTRIPTYLINE; TRANSCRIPTOME; CARRIER PROTEIN; CITALOPRAM; KXD1 PROTEIN, HUMAN; MATRIX METALLOPROTEINASE; MMP28 PROTEIN, HUMAN;

ADULT; ANTIDEPRESSANT ACTIVITY; ARTICLE; CORRELATION ANALYSIS; DEPRESSION; DRUG EFFECT; DRUG EFFICACY; FEMALE; GENE; GENE EXPRESSION; GENETIC ASSOCIATION; HUMAN; KXD1 GENE; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; MMP28 GENE; MOLECULAR BIOLOGY; PHARMACOGENETICS; PRIORITY JOURNAL; TRANSCRIPTOMICS; TREATMENT RESPONSE; CAUCASIAN; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED STUDY; DEPRESSIVE DISORDER, MAJOR; DRUG EFFECTS; EUROPE; GENETICS; METABOLISM; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ANTIDEPRESSIVE AGENTS; CARRIER PROTEINS; CITALOPRAM; COHORT STUDIES; DEPRESSIVE DISORDER, MAJOR; EUROPE; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENE EXPRESSION; HUMANS; MATRIX METALLOPROTEINASES, SECRETED; MICROARRAY ANALYSIS; NORTRIPTYLINE; TRANSCRIPTOME; TREATMENT OUTCOME;

EID: 84959176954     PISSN: 0924977X     EISSN: 18737862     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2015.10.009     Document Type: Article

References (35)

1. Belzeaux R., Bergon A., Jeanjean V., Loriod B., Formisano-TrÃziny C., Verrier L., Loundou A., Baumstarck-Barrau K., Boyer L., Gall V., Gabert J., Nguyen C., Azorin J.M., Naudin J., Ibrahim E.C. Responder and nonresponder patients exhibit different peripheral transcriptional signatures during major depressive episode. Trans. Psychiatry 2012, 2(11).
2. Belzeaux R., Formisano-Treziny C., Loundou A., Boyer L., Gabert J., Samuelian J.C., Feron F., Naudin J., Ibrahim E.C. Clinical variations modulate patterns of gene expression and define blood biomarkers in major depression. J. Psychiatr. Res. 2010, 44(16):1205-1213.
3. Benjamini Y., Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. Ser. B 1995, 57(1):289-300. (Methodological).
4. Cai C., Langfelder P., Fuller T.F., Oldham M.C., Luo R., van den Berg L.H., Ophoff R.A., Horvath S. Is human blood a good surrogate for brain tissue in transcriptional studies?. BMC Genom. 2010, 11:589.
5. Cattaneo A., Bocchio-Chiavetto L., Zanardini R., Milanesi E., Placentino A., Gennarelli M. Reduced peripheral brain-derived neurotrophic factor mRNA levels are normalized by antidepressant treatment. Int. J. Neuropsychopharmacol. 2010, 13(1):103-108.
6. Cattaneo A., Gennarelli M., Uher R., Breen G., Farmer A., Aitchison K.J., Craig I.W., Anacker C., Zunsztain P.A., McGuffin P., Pariante C.M. Candidate genes expression profile associated with antidepressants response in the GENDEP study: differentiating between baseline 'predictors' and longitudinal 'targets'. Neuropsychopharmacology 2013, 38(3):377-385.
7. Duman R.S., Heninger G.R., Nestler E.J. A molecular and cellular theory of depression. Archiv. Gen. Psychiatry 1997, 54(7):597-606.
8. Faul F., Erdfelder E., Lang A.G., Buchner A. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 2007, 39(2):175-191.
9. Frazer A., Benmansour S. Delayed pharmacological effects of antidepressants. Mol. Psychiatry 2002, 7(Suppl. 1):S23-S28.
10. Gaujoux R., Seoighe C. CellMix: a comprehensive toolbox for gene expression deconvolution. Bioinformatics 2013, 28(17):2211-2212.
11. Gerhold D.L., Jensen R.V., Gullans S.R. Better therapeutics through microarrays. Nat. Genet. 2002, 32:547-551.
12. Hennings J.M., Uhr M., Klengel T., Weber P., Putz B., Touma C., Czamara D., Ising M., Holsboer F., Lucae S. RNA expression profiling in depressed patients suggests retinoid-related orphan receptor alpha as a biomarker for antidepressant response. Transl. Psychiatry 2015, 5:e538.
13. HSCIC, 2013. Prescriptions Dispensed in the Community, Statistics for England-2002-2012. Health and Social Care Information Centre.
14. Johnson W.E., Li C., Rabinovic A. Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics 2007, 8(1):118-127.
15. Kálmán J., Palotás A., Juhász A., Rimanóczy Á., Hugyecz M., Kovács Z., Galsi G., Szabó Z., Pákáski M., Fehér L., Janka Z., Puskás L. Impact of venlafaxine on gene expression profile in lymphocytes of the elderly with major depression - evolution of antidepressants and the role of the "neuro-immune" system. Neurochem. Res. 2005, 30(11):1429-1438.
16. Langfelder P., Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics 2008, 9(1):559.
17. Lee H.K., Hsu A.K., Sajdak J., Qin J., Pavlidis P. Coexpression analysis of human genes across many microarray data sets. Genome Res. 2004, 14(6):1085-1094.
18. Lesch K.P., Schmitt A. Antidepressants and gene expression profiling: how to SNARE novel drug targets. Pharmacogenom. J. 2002, 2(6):346-348.
19. Liew C.C., Ma J., Tang H.C., Zheng R., Dempsey A.A. The peripheral blood transcriptome dynamically reflects system wide biology: a potential diagnostic tool. J. Lab. Clin. Med. 2006, 147(3):126-132.
20. Lunnon K., Ibrahim Z., Proitsi P., Lourdusamy A., Newhouse S., Sattlecker M., Furney S., Saleem M., Soininen H., Kloszewska I., Mecocci P., Tsolaki, M., Vellas B., Coppola G., Geschwind D., Simmons A., Lovestone S., Dobson R., Hodges A. Mitochondrial dysfunction and immune activation are detectable in early Alzheimer's disease blood. J Alzheimers Dis 2012, 30(3):685-710.
21. Mamdani F., Berlim M.T., Beaulieu M.M., Labbe A., Merette C., Turecki G. Gene expression biomarkers of response to citalopram treatment in major depressive disorder. Transl. Psychiatry 2011, 1:e13.
22. Montgomery S.A., Asberg M. A new depression scale designed to be sensitive to change. Br. J. Psychiatry 1979, 134:382-389.
23. Powell T.R., Tansey K.E., Breen G., Farmer A.E., Craig I.W., Uher R., McGuffin P., D'Souza U.M., Schalkwyk L.C. ATP-binding cassette sub-family F member 1 (ABCF1) is identified as a putative therapeutic target of escitalopram in the inflammatory cytokine pathway. J. Psychopharmacol. 2013, 27(7):609-615.
24. Shen, L., Sinai, M., 2013. GeneOverlap: test and visualize gene overlaps. /. http://shenlab-sinai.github.io/shenlab-sinai.
25. Sillaber I., Panhuysen M., Henniger M.S., Ohl F., Kuhne C., Putz B., Pohl T., Deussing J.M., Paez-Pereda M., Holsboer F. Profiling of behavioral changes and hippocampal gene expression in mice chronically treated with the SSRI paroxetine. Psychopharmacology 2008, 200(4):557-572.
26. Smyth G.K. limma: Linear Models for Microarray Data. Bioinformatics and Computational Biology Solutions Using R and Bioconductor 2005, 397-420. Springer, New York. R. Gentleman, V. Carey, W. Huber (Eds.).
27. Sullivan P.F., Fan C., Perou C.M. Evaluating the comparability of gene expression in blood and brain. Am J Med Genet B Neuropsychiatr Genet 2006, 141B(3):261-268.
28. Tansey, K.E., Guipponi, M., Perroud, N., Bondolfi, G., Domenici, E., Evans, D., Hall, S.K., Hauser, J., Henigsberg, N., Hu, X., Jerman, B., Maier, W., Mors, O., O'Donovan, M., Peters, T.J., Placentino, A., Rietschel, M., Souery, D., Aitchison, K.J., Craig, I., Farmer, A., Wendland, J.R., Malafosse, A., Holmans, P., Lewis, G., Lewis, C.M., Stensbà l, T.B., Kapur, S., McGuffin, P., Uher, R., 2012. Genetic Predictors of Response to Serotonergic and Noradrenergic Antidepressants in Major Depressive Disorder: A Genome-Wide Analysis of Individual-Level Data and a Meta-Analysis. PLoS Med. 9(10). p. e1001326.
29. Trivedi M.H., Rush A.J., Wisniewski S.R., Nierenberg A.A., Warden D., Ritz L., Norquist G., Howland R.H., Lebowitz B., McGrath P.J., Shores-Wilson K., Biggs M.M., Balasubramani G.K., Fava M. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR D: implications for clinical practice. Am. J. Psychiatry 2006, 163(1):28-40.
30. Uher, R., Huezo-Diaz, P., Perroud, N., Smith, R., Rietschel, M., Mors, O., Hauser, J., Maier, W., Kozel, D., Henigsberg, N., Barreto, M., Placentino, A., Dernovsek, M.Z., Schulze, T.G., Kalember, P., Zobel, A., Czerski, P.M., Larsen, E.R., Souery, D., Giovannini, C., Gray, J.M., Lewis, C.M., Farmer, A., Aitchison, K.J., McGuffin, P., Craig, I., 2009. Genetic predictors of response to antidepressants in the GENDEP project. Pharmacogenom. J. 9(4). pp. 225-233.
31. Uher R., Mors O., Rietschel M., Rajewska-Rager A., Petrovic A., Zobel A., Henigsberg N., Mendlewicz J., Aitchison K.J., Farmer A., McGuffin P. Early and delayed onset of response to antidepressants in individual trajectories of change during treatment of major depression: a secondary analysis of data from the Genome-Based Therapeutic Drugs for Depression (GENDEP) study. J. Clin. Psychiatry 2011, 72(11):1478-1484.
32. Undurraga J., Baldessarini R. Randomized, placebo-controlled trials of antidepressants for acute major depression: thirty-year meta-analytic review. Neuropsychopharmacology 2012, 37(4):851-864.
33. Ustun T.B., Ayuso-Mateos J.L., Chatterji S., Mathers C., Murray C.J. Global burden of depressive disorders in the year 2000. Br. J. Psychiatry 2004, 184:386-392.
34. Wang J., Duncan D., Shi Z., Zhang B. WEB-based GEne SeT AnaLysis Toolkit (WebGestalt): update 2013. Nucleic Acids Res. 2013, 41:W77-W83. (Web Server issue).
35. Wing J.K., Sartorius N., Üstün T.B. Diagnosis and Clinical Measurement in Psychiatry: A Reference Manual for SCAN 1998, Cambridge University Press, UK.